Mark Laible
-
- Breast Cancer Treatment Studies 7
-
- HER2/EGFR in Cancer Research 5
-
- Prostate Cancer Treatment and Research 3
-
- Gene expression and cancer classification 6
- Molecular Biology Techniques and Applications 5
- Advanced Biosensing Techniques and Applications 3
-
- Urinary and Genital Oncology Studies 3
- Bladder and Urothelial Cancer Treatments 3
In The Last Decade
Mark Laible
16 papers receiving 295 citations
Peers
Comparison fields: 5 of 54
- Cancer Research 101
- Oncology 111
- Pulmonary and Respiratory Medicine 66
- Molecular Biology 131
- Surgery 77
Countries citing papers authored by Mark Laible
This map shows the geographic impact of Mark Laible's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Laible with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Laible more than expected).
Fields of papers citing papers by Mark Laible
This network shows the impact of papers produced by Mark Laible. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Laible. The network helps show where Mark Laible may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Laible, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 17 | |
| 4 | 2021 | 8 | |
| 5 | 2020 | 0 | |
| 6 | 2019 | 8 | |
| 7 | 2019 | 0 | |
| 8 | 2018 | 7 | |
| 9 | 2018 | 3 | |
| 10 | 2017 | 63 | |
| 11 | 2017 | 14 | |
| 12 | 2017 | 22 | |
| 13 | 2016 | 27 | |
| 14 | 2016 | 42 | |
| 15 | 2016 | 28 | |
| 16 | 2016 | 26 | |
| 17 | 2015 | 1 | |
| 18 | 2013 | 23 | |
| 19 | 2008 | 12 |
About Mark Laible
Mark Laible is a scholar working on Cancer Research, Pathology and Forensic Medicine, Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 302 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), Gene expression and cancer classification (6 papers), Molecular Biology Techniques and Applications (5 papers), HER2/EGFR in Cancer Research (5 papers), Advanced Biosensing Techniques and Applications (3 papers), Urinary and Genital Oncology Studies (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Cancer Research (101 citations), Oncology (111 citations), Pulmonary and Respiratory Medicine (66 citations), Molecular Biology (131 citations) and Surgery (77 citations). Mark Laible has collaborated with scholars based in Germany, Italy and Finland. Frequent co-authors include Kornelia Schlombs, Ralph M. Wirtz, Sebastian Eidt, Uğur Şahin, Elke Veltrup, Peter Altevogt, Arndt Hartmann, Sotiris Lakis, Holger Sültmann and Sotirios Lakis. Their work appears in journals such as BMC Cancer, Cancer Research, Oncotarget, PLoS ONE and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.